Skip to main content
Premium Trial:

Request an Annual Quote

The BioCommerce Week Index: Mar 3, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(March 1, 2005)
Last Price
(
Feb. 22, 2005)
% Change
Agilent
A
24.48
23.48
4.26
Applied Biosystems
ABI
20.71
19.75
4.86
BD
BDX
59.88
58.67
2.06
Beckman
BEC
70.45
68.11
3.44
Bio-Rad
BIO
49.60
47.48
4.47
Bruker
BRKR
3.66
3.75
-2.40
GE
GE
35.22
35.35
-0.37
Harvard Bio
HBIO
4.22
4.62
-8.66
Invitrogen
IVGN
70.56
68.74
2.65
Molecular Devices
MDCC
20.93
20.37
2.75
PerkinElmer
PKI
22.20
22.28
-0.36
Sigma
SIAL
62.37
61.06
2.15
Stratagene
STGN
6.82
6.59
3.49
Thermo
TMO
27.32
27.14
0.66
Waters
WAT
48.50
48.03
0.98
Index Average
35.13
34.36
2.23

 

ABI Shares Up 5 Percent as
BCW Index Ends Two-Week Slide

Shares of Applied Biosystems closed up nearly 5 percent for the five-day period ending Tuesday and the BioCommerce Week Index ended a two-week slide.

ABI closed at $20.71, compared to last week's close of $19.75, after announcing a services collaboration with Deloitte Consulting at Pittcon this week. Bio-Rad, whose share price fell 17 percent last week after releasing its fourth-quarter results, gained nearly 5 percent back this week, while Agilent gained back the 4 percent it lost last week.

A total of 11 companies in the index charted improvements in their stock prices, ranging from Stratagene's 3.5 percent gain down to Thermo's 0.66 percent increase.

Shares of Harvard Bioscience dropped nearly 9 percent as the biggest loss on the week. Bruker dropped 2.4 percent, and GE and PerkinElmer fell a fraction.

Overall, the index improved 2 percent and is up 13 percent since its inception in September. For the week, the index outperformed S&P 500, which was up a fraction under 2 percent; the Dow, which rose about 1.6 percent; and the Nasdaq, which was up approximately 1.5 percent. The Amex pharma index climbed approximately 1.2 percent on the week while the Amex biotechnology index fell approximately 1.2 percent for the week.

 

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.